166 related articles for article (PubMed ID: 16620968)
1. PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma.
Proto-Siqueira R; Figueiredo-Pontes LL; Panepucci RA; Garcia AB; Rizzatti EG; Nascimento FM; Ishikawa HC; Larson RE; Falcão RP; Simpson AJ; Gout I; Filonenko V; Rego EM; Zago MA
Leuk Res; 2006 Nov; 30(11):1333-9. PubMed ID: 16620968
[TBL] [Abstract][Full Text] [Related]
2. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
3. The expression of PRAME in chronic lymphoproliferative disorders.
Proto-Siqueira R; Falcão RP; de Souza CA; Ismael SJ; Zago MA
Leuk Res; 2003 May; 27(5):393-6. PubMed ID: 12620290
[TBL] [Abstract][Full Text] [Related]
4. PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature.
Paydas S; Tanriverdi K; Yavuz S; Seydaoglu G
Leuk Res; 2007 Mar; 31(3):365-9. PubMed ID: 16914202
[TBL] [Abstract][Full Text] [Related]
5. Guess what: Chronic 13q14.3+/CD5-/CD23+ lymphocytic leukemia in blood and t(11;14)(q13;q32)+/CD5+/CD23- mantle cell lymphoma in lymph nodes!
Lima M; Pinto L; Dos Anjos Teixeira M; Canelhas A; Mota A; Cabeda JM; Silva C; Queirós ML; Fonseca S; Santos AH; Brochado P; Justiça B
Cytometry B Clin Cytom; 2003 Jan; 51(1):41-4. PubMed ID: 12500296
[TBL] [Abstract][Full Text] [Related]
6. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
[TBL] [Abstract][Full Text] [Related]
7. Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia.
Ortmann CA; Eisele L; Nückel H; Klein-Hitpass L; Führer A; Dührsen U; Zeschnigk M
Ann Hematol; 2008 Oct; 87(10):809-18. PubMed ID: 18587578
[TBL] [Abstract][Full Text] [Related]
8. Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy.
Griffioen M; Kessler JH; Borghi M; van Soest RA; van der Minne CE; Nouta J; van der Burg SH; Medema JP; Schrier PI; Falkenburg JH; Osanto S; Melief CJ
Clin Cancer Res; 2006 May; 12(10):3130-6. PubMed ID: 16707612
[TBL] [Abstract][Full Text] [Related]
9. The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome.
Oberthuer A; Hero B; Spitz R; Berthold F; Fischer M
Clin Cancer Res; 2004 Jul; 10(13):4307-13. PubMed ID: 15240516
[TBL] [Abstract][Full Text] [Related]
10. Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.
Kokhaei P; Palma M; Hansson L; Osterborg A; Mellstedt H; Choudhury A
Exp Hematol; 2007 Feb; 35(2):297-304. PubMed ID: 17258078
[TBL] [Abstract][Full Text] [Related]
11. Expression of the Rho-family GTPase gene RHOF in lymphocyte subsets and malignant lymphomas.
Gouw LG; Reading NS; Jenson SD; Lim MS; Elenitoba-Johnson KS
Br J Haematol; 2005 May; 129(4):531-3. PubMed ID: 15877735
[TBL] [Abstract][Full Text] [Related]
12. The CD45 isoform B220 identifies select subsets of human B cells and B-cell lymphoproliferative disorders.
Rodig SJ; Shahsafaei A; Li B; Dorfman DM
Hum Pathol; 2005 Jan; 36(1):51-7. PubMed ID: 15712182
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells.
Tanaka N; Wang YH; Shiseki M; Takanashi M; Motoji T
Leuk Res; 2011 Sep; 35(9):1219-25. PubMed ID: 21550659
[TBL] [Abstract][Full Text] [Related]
14. Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.
Schmitt M; Li L; Giannopoulos K; Chen J; Brunner C; Barth T; Schmitt A; Wiesneth M; Döhner K; Döhner H; Greiner J
Exp Hematol; 2006 Dec; 34(12):1709-19. PubMed ID: 17157168
[TBL] [Abstract][Full Text] [Related]
15. Characterization of immunoglobulin heavy and light chain gene expression in chronic lymphocytic leukemia and related disorders.
Nakahashi H; Tsukamoto N; Hashimoto Y; Koiso H; Yokohama A; Saitoh T; Uchiumi H; Handa H; Murakami H; Nojima Y; Karasawa M
Cancer Sci; 2009 Apr; 100(4):671-7. PubMed ID: 19220298
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia.
Spanaki A; Perdikogianni C; Linardakis E; Kalmanti M
Leuk Res; 2007 May; 31(5):639-42. PubMed ID: 16860864
[TBL] [Abstract][Full Text] [Related]
17. Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies.
Kokhaei P; Abdalla AO; Hansson L; Mikaelsson E; Kubbies M; Haselbeck A; Jernberg-Wiklund H; Mellstedt H; Osterborg A
Clin Cancer Res; 2007 Jun; 13(12):3536-44. PubMed ID: 17575216
[TBL] [Abstract][Full Text] [Related]
18. PRAME expression in hairy cell leukemia.
Arons E; Suntum T; Margulies I; Yuan C; Stetler-Stevenson M; Kreitman RJ
Leuk Res; 2008 Sep; 32(9):1400-6. PubMed ID: 18295331
[TBL] [Abstract][Full Text] [Related]
19. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
[TBL] [Abstract][Full Text] [Related]
20. Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.
Giannopoulos K; Li L; Bojarska-Junak A; Rolinski J; Dmoszynska A; Hus I; Greiner J; Renner C; Döhner H; Schmitt M
Int J Oncol; 2006 Jul; 29(1):95-103. PubMed ID: 16773189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
